For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.

(HealthDay News) — From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July ...

People with hypothyroidism may develop small intestinal bacterial overgrowth, which may be reduced by thyroid hormone therapy.

Testosterone plays a critical role in male sexual functioning but can also impact bone mass, fat distribution, muscle mass, ...

A recent study presented at ENDO 2025 reveals that artificial sweeteners like aspartame and sucralose, commonly found in diet ...

Story by Koji Uchida On Saturday, July 12th, at TACHIKAWA STAGE GARDEN, a special event titled "Yu-Gi-Oh! Anime Series 25th Duelist Live Kingdom" was held to celebrate the 25th anniversary of the ...

Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...

Adults with congenital adrenal hyperplasia treated with an oral nonsteroidal drug saw continued disease control with reduced ...

Liverpool won the 2024/25 Premier League title with limited options in midfield. Ryan Gravenberch took over No6 duties after ...

Pregnant Elsie Hewitt teased her "weird chaotic month" with Pete Davidson prior to announcing their baby news.

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...